SNT (SNT) Stock Price & Analysis
SNT (SNT) fell 3.04% to USD 2.47 as of June 10, 2026 at 03:39 UTC, according to Nexqual real-time market data.
SNT last closed at USD 2.55; the session ranged USD 2.4–2.58 on volume of 39,551 shares. Market capitalization is $57.69M, with a 52-week range of USD 2.4–5.34 (NGM). Source: Nexqual, June 10, 2026 at 03:39 UTC.
Key Statistics (as of June 10, 2026 at 03:39 UTC)
| Price | USD 2.47 |
|---|---|
| Change | ▼ 3.04% (down) |
| Previous Close | USD 2.55 |
| Open | USD 2.51 |
| Day Range | USD 2.4 – 2.58 |
| 52-Week Range | USD 2.4 – 5.34 |
| Volume | 39,551 shares |
| Market Cap | $57.69M |
| Exchange | NGM |
Technical Analysis (SNT)
Nexqual's technical model rates SNT "SELL" based on 2 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 03:39 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 35.68 (neutral) |
| vs SMA50 | Below (USD 2.8) |
| MACD | -0.07 (negative) |
Analyst Ratings (SNT)
Wall Street analysts rate SNT "None", per Nexqual as of June 10, 2026 at 03:39 UTC.
| Consensus Rating | None |
|---|
Earnings (SNT)
| Next Earnings Date | 2026-08-25 |
|---|
Source: Nexqual, June 10, 2026 at 03:39 UTC.
Financials & Fundamentals (SNT)
| Total Revenue | $36.01M |
|---|---|
| Revenue Growth (YoY) | -4.30% |
| Gross Margin | +63.91% |
| Operating Margin | -7.47% |
| Profit Margin | +3.79% |
| ROE | +3.37% |
| Debt / Equity | 1.31 |
| Current Ratio | 3.14 |
| Total Cash | $10.59M |
| Total Debt | $549,000 |
Source: Nexqual, June 10, 2026 at 03:39 UTC.
Financial Health Score (SNT)
Nexqual rates SNT's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 03:39 UTC.
| Growth | Weak — Revenue -4% YoY (latest Q), declining |
|---|---|
| Profitability | Weak — Not yet profitable — scaling phase |
| Balance Sheet | Strong — $11M cash, no debt |
| Cash Flow | Mixed — No data |
| Efficiency | Weak — ROE 3%, ROA 1.6% |
Ownership (SNT)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +48.65% |
| Shares Outstanding | 23.33M |
| Float | 13.48M |
| Short % of Float | +0.08% |
Source: Nexqual, June 10, 2026 at 03:39 UTC.
Leadership (SNT)
SNT is led by Fabien Haubert (age 50), Chief Executive Officer, per Nexqual as of June 10, 2026 at 03:39 UTC.
| Chief Executive Officer | Fabien Haubert (age 50) |
|---|---|
| Chief Financial Officer | Alicia Kelly (age 47) |
| Chief Operating Officer | Matthieu Currat (age 42) |
| Chief Technology Officer | Jeremy Weese P.Eng (age 48) |
| Executive Chairman of the Board | Gillon Beck (age 63) |
Major Backers & Investors (SNT)
Notable institutional backers of SNT include Grace & White Inc /ny, Renaissance Technologies, Janney Montgomery Scott LLC, according to Nexqual as of June 10, 2026 at 03:39 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Grace & White Inc /ny | 2.76% |
| Renaissance Technologies | 1.98% |
| Janney Montgomery Scott LLC | 0.72% |
| LPL Financial LLC | 0.22% |
| Juncture Wealth Strategies, Llc | 0.15% |
| Citadel | 0.14% |
Source: Nexqual, June 10, 2026 at 03:39 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| NTII | NEUROBIOLOGICAL TECHNOLOGIES IN | USD 0 | ▲ 0% |
| XTLB | XTL Biopharmaceuticals Ltd. | USD 2.32 | ▲ 12.62% |
| SGRP | SPAR Group, Inc. | USD 0.75 | ▲ 1.35% |
| MTEK | Maris-Tech Ltd. | USD 1.17 | ▼ 1.68% |
| TGEN | Tecogen Inc. | USD 5.67 | ▼ 1.22% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 03:39 UTC. This page is informational and not investment advice.